Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Hypertension. 2014 Mar 31;63(6):1345–1353. doi: 10.1161/HYPERTENSIONAHA.113.02804

Fig. 5. ASC-J9® treatment blocked THP-1 cells migration and adhesion into HUVECs, and foam cell formation.

Fig. 5

a. Western blot analysis showing AR protein levels in THP-1 cells upon ASC-J9® treatment. b. In vitro test of ASC-J9® effect on migration of THP-1 cells into HUVECs. THP-1 cells were treated with ASC-J9® (10 μM) for 2 days and used for the migration experiment. *p<0.05 c. In vitro test of ASC-J9® effect on adhesion of THP-1 cells onto HUVECs. **p<0.01 d. In vitro test of ASC-J9® effect on foam cell formation. THP-1 cells were treated with various concentrations of ASC-J9® for 2 days and used for the experiment. Quantitation is shown on the right. **p<0.01